June 16, 2017 10:31 AM EDT

Clancy joins the new team at Alexion, investment banker joins Flagship, Deeg quickly rises through ranks at Regulus

Emma Yasinski

→ CFO Paul Clancy left Biogen after 16 years to join Alexion. Under new CEO Ludwig Hantson, Alexion has been undergoing major staffing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Clancy joins the new team at Alexion, investment banker joins Flagship, Deeg quickly rises through ranks at Regulus

Emma Yasinski

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Updated: White House threatens ‘most favored nation’ plan to lower US drug prices, but many questions remain

Pharma investors brush off Trump’s ‘most favored nation’ plan as stocks rise

Watch Post-Hoc Live: Trump's 'most favored nation' plan to cut drug prices

GSK to pay $1.2B upfront to snag Boston Pharma’s mid-stage MASH hope

Bristol Myers CEO says America’s biopharma pole position is not guaranteed

It's been three months without a biotech IPO

Clan­cy joins the new team at Alex­ion, in­vest­ment banker joins Flag­ship, Deeg quick­ly ris­es through ranks at Reg­u­lus

Sign up to read this article for free.

more like this

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Clancy joins the new team at Alexion, investment banker joins Flagship, Deeg quickly rises through ranks at Regulus